Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a ...

Summary by Hastings Tribune
AUSTIN, Texas and DURHAM, N.C., June 05, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3-blocking antibodies for the treatment of patients with inflammatory and…

2 Articles

Hastings TribuneHastings Tribune
Center

Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a ...

AUSTIN, Texas and DURHAM, N.C., June 05, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3-blocking antibodies for the treatment of patients with inflammatory and…

·Nebraska, United States
Read Full Article
stocktitan.netstocktitan.net

Inside Shattuck Labs' June 8 webcast on experimental inflammatory antibody

Phase 1 SL-325 data, spanning safety to immunogenicity, will be detailed in Shattuck Labs' June 8, 8:00 a.m. ET investor webcast plus pipeline update replay.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news on Friday, June 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Austin, Texas icon

Austin, Texas

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal